Translational research involving oxidative stress and diseases of aging

Area of Science:

• Biochemistry
• Pharmacology
• Pathology

Background:

• Reactive oxidant species (ROS) are implicated in inflammation, chronic diseases, and various pathological conditions.
• Targeting ROS for therapeutic benefit presents significant challenges due to their complex roles in biological systems.
• The development of effective ROS-suppressing therapeutics requires careful consideration of their operational efficacy in vivo.

Purpose of the Study:

• To critically evaluate the role of ROS as a therapeutic target in disease.
• To discuss the challenges associated with translating antioxidant properties from chemical systems to biological ones.
• To explore the utility of preclinical models in assessing the efficacy of ROS-targeting agents.

Main Methods:

• Review of existing evidence on ROS in disease pathogenesis.
• Analysis of the challenges in developing antioxidants for biological systems.
• Discussion of preclinical model requirements for evaluating ROS-dependent processes.
• Case study: Translational research on nitrones for acute ischemic stroke and cancer.

Main Results:

• ROS exacerbation is common in inflammatory and age-related diseases.
• Antioxidant efficacy in vitro does not always translate to in vivo effectiveness.
• Preclinical models are crucial for validating ROS involvement and therapeutic impact.
• Nitrones show promise as therapeutic agents for stroke and cancer.

Conclusions:

• Targeting ROS requires a nuanced understanding of their dual role in health and disease.
• Effective therapeutic development necessitates robust preclinical validation of ROS-dependent mechanisms.
• Translational research, exemplified by nitrone development, is key to advancing ROS-targeted therapies.